Effects of embedded micro-mindfulness on psychological symptoms in patients with advanced cancer receiving palliative care: a prospective controlled study.
Qin Zhang, Qianer Li, Aiping Deng, Dan Yang, Dan Jia
Frontiers in Oncology August 26, 2026 DOI: 10.3389/fonc.2026.1916107 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Prospective, non-randomized observational study Peer reviewed |
|---|---|
| Sample size | 243 |
| Population | Patients with advanced cancer receiving palliative care at West China Hospital |
| Intervention | Micro-mindfulness program |
| Duration | 4 weeks, with weekly assessments |
| Measures | GAD-7, PHQ-9, Distress Thermometer (DT), two-item Insomnia Severity Index (ISI-2), Numeric Rating Scale (NRS) |
| Topics | End-of-life distress Meditation |
| Keywords | Advanced cancer Palliative care Anxiety and depression Psychological symptoms Micro-mindfulness |
| Key findings | Patients who participated in an embedded micro-mindfulness program alongside usual care showed greater reductions over four weeks in anxiety, depressive symptoms, psychological distress, and sleep problems than those receiving usual care alone, while pain intensity did not differ between groups. The authors argue these findings support further evaluation of the brief program as a supportive-care strategy in advanced cancer. |
Abstract
Objective: To evaluate changes in psychological distress, anxiety and depressive symptoms, sleep problems, and pain intensity associated with participation in an embedded micro-mindfulness program among patients with advanced cancer receiving palliative care, and to explore factors associated with psychological symptom response.
Methods: This single-center, prospective, non-randomized observational study included 243 patients with advanced cancer receiving palliative care at West China Hospital. Patients who participated in the departmental micro-mindfulness program in addition to usual care comprised the MM group (n = 121), whereas those who received usual care without participating in the program comprised the UC group (n = 122). Outcomes were assessed at baseline and weekly for 4 weeks. Primary outcomes were anxiety and depressive symptoms assessed using the GAD-7 and PHQ-9, respectively. Secondary outcomes included psychological distress assessed using the Distress Thermometer (DT), sleep problems assessed using the two-item Insomnia Severity Index (ISI-2), and pain intensity assessed using the Numeric Rating Scale (NRS).
Results: Baseline characteristics were comparable between groups. Significant group × time interactions were observed for GAD-7 (P = 0.001), PHQ-9 (P = 0.002), DT (P < 0.001), and ISI-2 (P < 0.001), with greater reductions over time observed in the MM group. The group × time interaction for NRS was not significant (P = 0.371). In the MM group, 73 patients (60.3%) achieved psychological symptom response.
Conclusion: Embedded micro-mindfulness was associated with greater improvements in anxiety, depressive symptoms, psychological distress, and sleep problems, but not pain intensity. These findings support further evaluation of this brief program as a supportive-care strategy for patients with advanced cancer receiving palliative care.
Comparable studies
Other non-randomized and open-label trials on end-of-life distress, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study) Patients with advanced cancer and moderate to severe major depressive disorder | 2023 | Single-arm, open-label phase II trial | n = 20 |
| Mindfulness and compassion training on daily work with patients and within the multiprofessional palliative care team: a retrospective self-assessment study Employees of a university-based specialized palliative care unit | 2023 | Observational cohort (pre-post self-assessment) | n = 24 |
| Intranasal Ketamine for Existential Distress in Advanced Cancer. Patients with advanced cancer receiving palliative care | 2026 | Secondary analysis of a clinical trial | n = 15 |
| PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trial Adults with advanced, incurable illness and estimated prognosis of 1–12 months,... | 2026 | Open label, single-arm clinical trial | n = 20 |
| Effect of mindfulness-based stress reduction on nursing interns' death anxiety, stress, and palliative care self-efficacy during oncology end-of-life training. Final-year Bachelor of Science in nursing interns at Prince Sattam Bin Abdulaziz... | 2026 | Quasi-experimental pre-post study | n = 120 |
Citations in the library
Cites 14
- How long does a mindfulness‐based stress reduction program need to be? A review of class contact hours and effect sizes for psychological distress Journal of Clinical Psychology March 23, 2009
- Effects of mindfulness-based stress reduction on quality of life of breast cancer patient: A systematic review and meta-analysis. PLoS One 2024
- Mindfulness to enhance quality of life and support advance care planning: a pilot randomized controlled trial for adults with advanced cancer and their family caregivers. BMC Palliative Care September 28, 2024
- Effectiveness of Web-Based Mindfulness-Based Interventions for Patients With Cancer: Systematic Review and Meta-Analyses. Journal of Medical Internet Research June 25, 2024
- Cognitive-behavioral and mindfulness-based interventions for distress in patients with advanced cancer: A meta-analysis. Psycho-Oncology 2024
and 9 more in the library